Dyslipidemia: recommendations for diagnosis and treatment at the first level of medical contact.

IF 0.6 4区医学 Q3 MEDICINE, GENERAL & INTERNAL

Gaceta medica de Mexico Pub Date : 2024-01-01 DOI:10.24875/GMM.M24000916

Ma de Lourdes Basurto, Miguel Abdo-Francis, Carlos A Aguilar-Salinas, Lourdes J Balcázar-Hernández, Gabriela Borrayo-Sánchez, Graciela E Castro-Narro, Adolfo Chávez-Negrete, Alejo Díaz-Aragón, José M Enciso-Muñoz, Carlos Fernández-Barros, Aldo Ferreira-Hermosillo, Antonio González-Chávez, Arturo Guerra-López, Rita Gómez-Díaz, Mario Molina-Ayala, César Rodríguez-Gilabert, Edith Ruiz-Gastelum, Juan C Tomás-López, Héctor R Vargas-Sánchez, Edith Ruiz-Gastelum

{"title":"Dyslipidemia: recommendations for diagnosis and treatment at the first level of medical contact.","authors":"Ma de Lourdes Basurto, Miguel Abdo-Francis, Carlos A Aguilar-Salinas, Lourdes J Balcázar-Hernández, Gabriela Borrayo-Sánchez, Graciela E Castro-Narro, Adolfo Chávez-Negrete, Alejo Díaz-Aragón, José M Enciso-Muñoz, Carlos Fernández-Barros, Aldo Ferreira-Hermosillo, Antonio González-Chávez, Arturo Guerra-López, Rita Gómez-Díaz, Mario Molina-Ayala, César Rodríguez-Gilabert, Edith Ruiz-Gastelum, Juan C Tomás-López, Héctor R Vargas-Sánchez, Edith Ruiz-Gastelum","doi":"10.24875/GMM.M24000916","DOIUrl":null,"url":null,"abstract":"<p><p>Cardiovascular disease is the main cause of mortality in Mexico as well as the rest of the world, with dyslipidemia being one of the main risk factors. Despite the importance of its epidemiological impact, there is still -among primary care physicians- a lack of knowledge ranging from the basic concepts for diagnosis to the most recent recommendations for treatment. This document consisting of 10 questions is done by experts in this field. A total of 22 recommendations arise using Delphi methodology. The recommendations include the measurement of the lipid profile starting at 20 years of age, the treatment goals for patients according to their risk, the follow-up of patients with dyslipidemia, and the management approach in primary and secondary prevention.</p>","PeriodicalId":12736,"journal":{"name":"Gaceta medica de Mexico","volume":"160 4","pages":"354-362"},"PeriodicalIF":0.6000,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Gaceta medica de Mexico","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.24875/GMM.M24000916","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}

引用次数: 0

Abstract

Cardiovascular disease is the main cause of mortality in Mexico as well as the rest of the world, with dyslipidemia being one of the main risk factors. Despite the importance of its epidemiological impact, there is still -among primary care physicians- a lack of knowledge ranging from the basic concepts for diagnosis to the most recent recommendations for treatment. This document consisting of 10 questions is done by experts in this field. A total of 22 recommendations arise using Delphi methodology. The recommendations include the measurement of the lipid profile starting at 20 years of age, the treatment goals for patients according to their risk, the follow-up of patients with dyslipidemia, and the management approach in primary and secondary prevention.

查看原文本刊更多论文

血脂异常：建议在医疗接触的第一级诊断和治疗。

在墨西哥和世界其他地区，心血管疾病是导致死亡的主要原因，而血脂异常是主要危险因素之一。尽管其在流行病学方面具有重要影响，但初级保健医生仍然缺乏从诊断的基本概念到最新治疗建议的知识。本文档由10个问题组成，由该领域的专家完成。采用德尔菲法共提出22项建议。建议包括从20岁开始测量血脂，根据患者的风险确定治疗目标，对血脂异常患者进行随访，以及一级和二级预防的管理方法。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Gaceta medica de Mexico 医学-医学：内科

CiteScore

1.00

自引率

0.00%

发文量

216

审稿时长

6-12 weeks

期刊介绍： Gaceta Médica de México México is the official scientific journal of the Academia Nacional de Medicina de México, A.C. Its goal is to contribute to health professionals by publishing the most relevant progress both in research and clinical practice. Gaceta Médica de México is a bimonthly peer reviewed journal, published both in paper and online in open access, both in Spanish and English. It has a brilliant editorial board formed by national and international experts.